The Exhaustive Commentary on the Drugs and Cosmetics Act, 1940, authored by Shri Sushant Mahapatra, Advocate - Supreme Court of India, was officially launched on September 7, 2024. Hon'ble Justice JK Maheshwari, Judge of the Supreme Court, graced the event as the Chief Guest and contributed a foreword to this significant work.
The Exhaustive Commentary contains:
- Detailed Analysis of Each Sec 1 to 38 of the Drugs and Cosmetics Act, 1940
- Commentary on Provisions Related To Suspension And Cancellation of License, Power of Central Licensing Authority, Change of Labels, Inscriptions, Marketer’s Responsibility, Loan License Provisions, Prohibition on Advertisement, Etc.
- Detailed Analysis of Power of Drug Inspectors,
- In-depth Analysis of Sample Collection and Procedure to be Followed.
- Testing of samples by Government Analysts and Protocol to be followed, Time Limits For Testing
- Right To Receive Samples, Challenging Reports, and the Conclusiveness of reports
- Failure to Challenge Report within 28 Days and Remedies
- Period of Limitation within which Complaint will be Filed
- Double Jeopardy
- Cognizance By Court of Sessions Not Tenable
- Cognizance Without Application By Magistrate
- Police officers and Power of Arrest under the D&C Act
- Bail Provisions
- Liability of Directors and When Not Liable
- Trial By Special Court
- Applicability of IPC, CrPC, BNS, BNSS
- Applicability of Jan Vishwas Act (Compounding of offences)
With over 900 judgments and Allied rules -
Authored by Sushant Mahapatra (Advocate - Supreme Court of India) , Foreword by Justice J.K. Maheshwari (Judge, Supreme Court of India)
Featuring over 900 judgments and related rules—don’t miss your chance to explore this essential resource, now available at: https://lexipharma.com/subscription!
